Estonia Pharmaceuticals & Healthcare Report Q4 2013 - New Study Released
BMI View: Strong Q113 results underpin our expectations for further growth in Estonia's pharmaceutical sales in 2013. An improving macroeconomic picture, real wage growth and higher employment figures point to a rise in state tax revenues. We therefore expect funding for healthcare to rise, particularly in light of the country's ageing population. Nevertheless, on an absolute basis, the Estonian pharmaceutical market remains relatively small in comparison to regional markets in Central and Eastern Europe. Despite its transparent regulatory policies, business-friendly...
View full press release